E. Gardner

1.2k total citations
25 papers, 806 citations indexed

About

E. Gardner is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, E. Gardner has authored 25 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cell Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in E. Gardner's work include Skin and Cellular Biology Research (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Erythropoietin and Anemia Treatment (3 papers). E. Gardner is often cited by papers focused on Skin and Cellular Biology Research (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Erythropoietin and Anemia Treatment (3 papers). E. Gardner collaborates with scholars based in United States, Australia and Italy. E. Gardner's co-authors include D. Dahl, A. Bignami, C. J. Crosby, Anthony J. Trevor, Sin-Lam Chan, Shoko Nogusa, Donna M. Murasko, Hemendra N. Bhargava, Enrique González and Donald Y. Shirachi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neurochemistry and European Heart Journal.

In The Last Decade

E. Gardner

25 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Gardner United States 12 331 321 216 140 71 25 806
Nadia Lelutiu United States 10 438 1.3× 139 0.4× 329 1.5× 46 0.3× 73 1.0× 12 1.0k
L. A. Martin United States 17 374 1.1× 108 0.3× 418 1.9× 56 0.4× 131 1.8× 34 876
U. Schaeppi Switzerland 15 212 0.6× 183 0.6× 189 0.9× 19 0.1× 93 1.3× 42 892
Monique Lazar France 13 160 0.5× 134 0.4× 513 2.4× 45 0.3× 31 0.4× 22 805
Richard M. Denney United States 15 415 1.3× 64 0.2× 410 1.9× 72 0.5× 36 0.5× 35 1.1k
Douglas J. Swanson United States 19 222 0.7× 164 0.5× 402 1.9× 69 0.5× 28 0.4× 63 1.1k
Robert A. Furlong United Kingdom 19 529 1.6× 60 0.2× 679 3.1× 162 1.2× 48 0.7× 32 1.5k
Jordi Aleu Spain 17 235 0.7× 110 0.3× 418 1.9× 79 0.6× 38 0.5× 25 846
D. O'Shaughnessy United Kingdom 10 438 1.3× 49 0.2× 381 1.8× 53 0.4× 216 3.0× 14 939
J. Edward Fisher United States 20 416 1.3× 48 0.1× 174 0.8× 32 0.2× 105 1.5× 41 1.1k

Countries citing papers authored by E. Gardner

Since Specialization
Citations

This map shows the geographic impact of E. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gardner more than expected).

Fields of papers citing papers by E. Gardner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gardner. The network helps show where E. Gardner may publish in the future.

Co-authorship network of co-authors of E. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of E. Gardner. A scholar is included among the top collaborators of E. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gardner. E. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stub, Dion, Sonny Palmer, Samer Noaman, et al.. (2024). The impact of diabetes on cardiac remodelling after transcatheter aortic valve implantation. European Heart Journal. 45(Supplement_1). 1 indexed citations
2.
Gardner, E.. (2005). Endocannabinoid signaling system and brain reward: Emphasis on dopamine. Pharmacology Biochemistry and Behavior. 81(2). 263–284. 298 indexed citations
3.
Thanos, Panayotis K., et al.. (2005). The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacology Biochemistry and Behavior. 81(1). 190–197. 79 indexed citations
4.
Gardner, E., Enrique González, Shoko Nogusa, & Donna M. Murasko. (2005). Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine. 24(10). 1609–1614. 54 indexed citations
5.
Gardner, E., et al.. (2004). Our Nig; or, Sketches from the Life of a Free Black. African American Review. 38(4). 715–715. 28 indexed citations
6.
Menon, Jaishri, E. Gardner, & Stephen G. Vail. (2000). Developmental implications of differential effects of calcium in tail and body skin of anuran tadpoles. Journal of Morphology. 244(1). 31–43. 6 indexed citations
7.
Ps, Parfrey, et al.. (1994). The feasibility and efficacy of early discharge planning initiated by the admitting department in two acute care hospitals.. PubMed. 17(2). 88–96. 22 indexed citations
8.
Gardner, E. & D. Dahl. (1987). Immunological study of a neurofilament protein variant (S150) with polyclonal and monoclonal antibodies. Biochimica et Biophysica Acta (BBA) - General Subjects. 926(3). 280–286. 2 indexed citations
9.
Dahl, D., E. Gardner, & C. J. Crosby. (1987). Axonal maturaion in development—I. Characterization of monoclonal antibodies reacting with axon‐specific neurofilament epitopes. International Journal of Developmental Neuroscience. 5(1). 17–23. 25 indexed citations
10.
Dahl, D., C. J. Crosby, E. Gardner, & A. Bignami. (1986). Delayed phosphorylation of the largest neurofilament protein in rat optic nerve development. Journal of Neuroscience Research. 15(4). 513–519. 46 indexed citations
11.
Lewis, J. P., et al.. (1985). Partial characterization of an erythropoiesis inhibitory factor. Biochemical Medicine. 33(1). 8–16. 1 indexed citations
12.
Gardner, E., D. Dahl, & A. Bignami. (1984). Formation of 10‐nanometer filaments from the 150k‐dalton neurofilament protein in vitro. Journal of Neuroscience Research. 11(2). 145–155. 58 indexed citations
13.
Gardner, E.. (1978). The initial US clinical experience in the management of schizophrenic patients with bromperidol.. PubMed. 78(1). 134–46. 2 indexed citations
14.
Lewis, J. P., et al.. (1975). A comparison of four preparations of erythropoiesis regulatory factors. Biochemical Medicine. 14(4). 399–410. 7 indexed citations
15.
Chan, Sin-Lam, E. Gardner, & Anthony J. Trevor. (1973). Improved method of large scale purification of acetylcholinesterase from the electric eel (Electrophorus electricus) by affinity chromatography. Cellular and Molecular Life Sciences. 29(5). 638–639. 5 indexed citations
16.
Chan, Sin-Lam, Donald Y. Shirachi, Hemendra N. Bhargava, E. Gardner, & Anthony J. Trevor. (1972). PURIFICATION AND PROPERTIES OF MULTIPLE FORMS OF BRAIN ACETYLCHOLINESTERASE (EC 3.1.1.7)1. Journal of Neurochemistry. 19(12). 2747–2758. 70 indexed citations
17.
Gardner, E., et al.. (1969). Dialysis as a tool in the study of erythropoietin.. PubMed. 73(1). 154–62. 9 indexed citations
18.
Gardner, E., et al.. (1967). Potentiation of Purified Erythropoietin with Serum Proteins*. British Journal of Haematology. 13(3). 317–322. 8 indexed citations
19.
Lewis, J. P., et al.. (1967). Fractionation of Erythropoietin by Selective Membrane Permeability. Acta Haematologica. 38(6). 372–376. 3 indexed citations
20.
Lange, R. D., et al.. (1964). Neutralization of the Biological Activity of Erythropoietin by Immune Sera*. British Journal of Haematology. 10(1). 69–74. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadia Lelutiu Breakdown of academic impact, for papers by L. A. Martin Breakdown of academic impact, for papers by U. Schaeppi Breakdown of academic impact, for papers by Monique Lazar Breakdown of academic impact, for papers by Richard M. Denney Breakdown of academic impact, for papers by Douglas J. Swanson Breakdown of academic impact, for papers by Robert A. Furlong Breakdown of academic impact, for papers by Jordi Aleu Breakdown of academic impact, for papers by D. O'Shaughnessy Breakdown of academic impact, for papers by J. Edward Fisher
Rankless by CCL
2026